Pandox's objective is to generate a good risk-adjusted total return and at the same time ensure good liquidity in the company's shares.

Pandox is listed on Nasdaq Stockholm Large Cap under the trade symbol PNDX B, since 18 June, 2015. The total number of diluted outstanding shares is 157,499,999, whereof 75,000,000 A shares and 82,499,999 B shares.

The information is delayed by 15 minutes.